← BACK TO $PLTR
$PLTRBull claim
Aug 4, 2026
The claim

“PLTR is still set up for a $1 trillion valuation as a conservative outcome, supported by 93% revenue growth and accelerating commercial expansion.”

Why he says it — point by point

FAVORABLE & AGAINST · BOTH KEPT

Why

we got revenue of 1.94 billion. That's a 93% growth. We've got adjusted EPS at .41 beating by 17%.

We got US commercial 764 million up 150%. We got rule of 40 of 155 operating margin of 62%.

support · $764support · $155

We got US commercial remaining deal value of 6.2 billion up 124%.

support · $6.2

the switching cost out of Palunteer are literally not surmountable, impossible.

Commercial revenue is at 149% growth.

A reverse calculation shows you that a terminal PE of 2030 of 40 gives us 61% revenue growth in order to hit that target.

target · 40×

the $1 trillion case is not a case for acceleration. It's a case that's built on Palunteer decelerating revenue growth.

what I'm doing, I'll tell you exactly. You have to follow two simple rules with Palunteer

Risk

Palunteer has one of the biggest, if not the biggest keyman risk in the entire stock market. If Alex Karp leaves, I don't think this company is worth a lot. It has obviously the pricing issue. If all of a sudden everybody piles into Palunteer, takes it up to $600 per share in two years. Yeah, that might be a problem What if commercial growth slows down? What if government slows down? Right? That could happen.

target · $600

The structured call

Direction
Bullish
Catalyst
Target
$367.00 · vs $$162.66 on publish day

The receipt

YouTube · 1:541:54

“PLTR is still set up for a $1 trillion valuation as a conservative outcome, supported by 93% revenue growth and accelerating commercial expansion.”

From "If you are a PALANTIR shareholder….GET READY"
Open the source at 1:54 →

Publish-day price $$162.66 · the claim is anchored to the moment it was said.

Tom Nash on $PLTR, over time

Full profile →

How this voice has moved on the ticker. We flag contradictions — as behavior, never a score.

This is the only tracked claim from this analyst on the ticker so far.

This receipt is public & free — always.
The full stance archive and CSV export are part of your trial.
This is a record of what one analyst said on one thesis, with the clip — not a recommendation, not a verdict, not a score. The opposing case is linked above.